Dexmedetomidine Might Exacerbate Acute Kidney Injury, While Midazolam Might Have a Postconditioning Effect: A Rat Model of Lipopolysaccharide-Induced Acute Kidney Injury-Reference-Cited by-同舟云学术

Dexmedetomidine Might Exacerbate Acute Kidney Injury, While Midazolam Might Have a Postconditioning Effect: A Rat Model of Lipopolysaccharide-Induced Acute Kidney Injury

Published:2023-10-25 Issue:5 Volume:90 Page:387-397
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Hata Akiko¹,Yamamoto Makiko¹,Iwasaki Masae¹,Morita Tomonori¹,Ishikawa Masashi¹,Sakamoto Atsuhiro¹

Affiliation:

1. Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jnms/90/5/90_JNMS.2023_90-406/_pdf

Reference33 articles.

1. 1. Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016 Feb 1;193 (3):259-72.

2. 2. Gomez H, Kellum JA. Sepsis-induced acute kidney injury. Curr Opin Crit Care. 2016 Dec;22 (6):546-53.

3. 3. Yasuda H, Kato A, Fujigaki Y, Hishida A; Shizuoka Kidney Disease Study Group. Incidence and clinical outcomes of acute kidney injury requiring renal replacement therapy in Japan. Ther Apher Dial. 2010 Dec;14 (6):541-6.

4. 4. Matsuda A, Jacob A, Wu R, et al. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. J Nippon Med Sch. 2012;79 (1):4-18.

5. 5. Chen Y, Luan L, Wang C, et al. Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS/NO signaling pathway in rats. Nitric Oxide. 2019 Apr 1;85:1-9.